Perspective Therapeutics (CATX) FCF Margin Growth (1y) (2011 - 2023)
Perspective Therapeutics (CATX) FCF Margin Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -473.00 |
| 10 | Perspective Therapeutics | 396.34 Mn | 396.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -38,477.00 |
| Jun 30, 2023 | -49,303.00 |
| Mar 31, 2023 | -43,122.00 |
| Sep 30, 2022 | -493.00 |
| Mar 31, 2022 | -2,237.00 |
| Dec 31, 2021 | 13,302.00 |
| Sep 30, 2021 | -6,447.00 |
| Mar 31, 2021 | 400.00 |
| Dec 31, 2020 | 2,798.00 |
| Sep 30, 2020 | 1,352.00 |
| Jun 30, 2020 | 1,762.00 |
| Mar 31, 2020 | 4,474.00 |
| Dec 31, 2019 | 160.00 |
| Sep 30, 2019 | 7,806.00 |
| Jun 30, 2019 | 4,102.00 |
| Mar 31, 2019 | -239.00 |
| Dec 31, 2018 | 4,107.00 |
| Sep 30, 2018 | 3,112.00 |
| Jun 30, 2018 | 1,028.00 |
| Mar 31, 2018 | 4,624.00 |